operating-guidelines-dhbs-providers-covid-19-vaccine-immunisation-programme-08Mar2022 Final

Page 72

Pfizer Vaccine administration and observation For more information see IMAC guidelines found on the IMAC website and the Immunisation handbook Section 2.2 for the correct vaccine administration process.

Table 18.1 – pre-vaccination greeting and verify identity Step

Action On arrival at the vaccination site, the vaccinator/site administrator will greet the consumer and ask whether they have any COVID-19 symptoms as per standard site practices*.

Please note: Greet consumer, conduct COVID-19 health check

• People who have a confirmed COVID-19 infection, should not be vaccinated until they have had the appropriate recovery period • People who have symptoms of COVID-19 should be advised to stay at home and get a test. They can be vaccinated once they have a negative test result and symptoms are mild only. • People who live with someone who has COVID-19are a household contact and are advised to go home and follow the specific advice public health advice for testing. • People who are significantly unwell are advised to wait until they are better before getting the vaccine; however, note that mild symptoms are not a contra-indication. People in this situation are advised to discuss their symptoms with their GP or vaccine provider. • People who have been advised to self-isolate, stay at home, are under an isolation order or are waiting on a test result, should have their appointment deferred. • Please see the Vaccination Site screening questions below for questions related to clinical assessment. • If a provider wishes to vaccinate a higher risk consumer (someone who answered yes to the screening questions), providers should follow the ‘vaccination in high-risk or screen ‘positive’ consumers’ section in the Operating Guidelines.

Version 34.0 Page 72


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Appendix K: Vaccination practice variation according to the COVID-19 Protection Framework changes

5min
pages 168-169

Appendix G: Vaccination site screening questions

2min
page 159

Appendix J: Risk mitigations for vaccination sites

2min
page 167

Appendix E: CVIP logistics overview/cheat sheets

4min
pages 156-157

Appendix D: Logistics and inventory management

1min
page 155

Incidents

6min
pages 137-141

Variations

1min
page 142

Affected persons under the Vaccinations Order

4min
pages 128-130

National Immunisation Booking System

11min
pages 131-136

Home vaccinations

2min
pages 125-126

Mobile vaccination team

1min
page 124

COVID-19 Trial Vaccinations

1min
page 127

Vaccination in Hospital

1min
page 123

Vaccination and Surveillance Testing

1min
page 122

Third primary dose for severely immunocompromised

1min
page 121

Section F: Additional programme guidance, variations and incidents

1min
page 117

Vaccination in high-risk or screened ‘positive’ consumers

5min
pages 118-120

Novavax Operational phase

1min
page 108

Novavax Vaccine administration and observation

8min
pages 111-116

Novavax Preparation of doses

2min
pages 109-110

Booking and scheduling

1min
page 107

Section E: Novavax (Nuvaxovid) COVID-19 Vaccine

1min
page 106

AstraZeneca Vaccine administration and observation

8min
pages 100-105

AstraZeneca Preparation of doses

2min
pages 98-99

AstraZeneca Operational phase

1min
page 97

Paediatric Pfizer Vaccine administration and observation

9min
pages 89-94

Section D: AstraZeneca COVID-19 Vaccine

1min
page 95

Booking and scheduling

1min
page 96

Paediatric Pfizer Preparation of doses

3min
pages 86-88

Vaccine safety and additional considerations for consumers aged 5 to 11 years

1min
page 85

Pfizer Vaccine administration and observation

13min
pages 72-81

Booking and scheduling

3min
pages 62-64

Vaccinating consumers aged 12 to 15 years

1min
page 68

Pfizer Preparation of doses

4min
pages 69-71

Pfizer Operational phase

2min
pages 66-67

Protecting security and privacy

1min
page 65

Becoming a COVID-19 Vaccination site

1min
page 60

Site readiness and closure

1min
page 59

Disposal of consumables, vaccine, and vaccine packaging

2min
pages 57-58

COVID-19 Immunisation Register

3min
pages 29-31

Preparing the vaccination workforce

7min
pages 22-26

Infection prevention and control (IPC

2min
pages 27-28

Section A: Ready to vaccinate

1min
page 15

Site considerations

7min
pages 18-21

Equipment ordering and demand planning

7min
pages 33-38

Vaccine storage and handling

8min
pages 39-44

Logistics

1min
page 32
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.